About the journal
Expert Opinion on Therapeutic Targets is a journal published by Taylor & Francis in United Kingdom. It is listed in MEDLINE according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Taylor & Francis
- ISSN
- 1472-8222 · 1744-7631
- Country
- United Kingdom
- Access
- Not open access / not declared
- Declared peer-review model
- peer_review
- Official website
- http://informahealthcare.com/loi/ett
Index listings
- MEDLINE · 2002-01-01
- Indexing
- MEDLINE
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
2695
Last recorded publication year
2026
h-index
128
i10-index
1859
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 99%
- ORCID iDs in current deposits
- 31%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101127833
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Cytokine Signaling Pathways and Interactions
- Cytokine Signaling Pathways and Interactions
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- PI3K/AKT/mTOR signaling in cancer
- PI3K/AKT/mTOR signaling in cancer
- Peptidase Inhibition and Analysis
- Ion channel regulation and function
Show all subjects (50)
- Peptidase Inhibition and Analysis
- Ion channel regulation and function
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Cell death mechanisms and regulation
- Cell death mechanisms and regulation
- Histone Deacetylase Inhibitors Research
- Histone Deacetylase Inhibitors Research
- Angiogenesis and VEGF in Cancer
- Angiogenesis and VEGF in Cancer
- Protein Kinase Regulation and GTPase Signaling
- Protein Kinase Regulation and GTPase Signaling
- Neuropeptides and Animal Physiology
- Neuropeptides and Animal Physiology
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Neuroscience and Neuropharmacology Research
- Cancer-related Molecular Pathways
- Neuroscience and Neuropharmacology Research
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
- Protease and Inhibitor Mechanisms
- Cancer Cells and Metastasis
- Ubiquitin and proteasome pathways
- Protease and Inhibitor Mechanisms
- Ubiquitin and proteasome pathways
- Cancer Mechanisms and Therapy
- Cancer Mechanisms and Therapy
- Receptor Mechanisms and Signaling
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- Receptor Mechanisms and Signaling
- Nuclear Receptors and Signaling
- Tryptophan and brain disorders
- Nuclear Receptors and Signaling
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Monoclonal and Polyclonal Antibodies Research
- Tryptophan and brain disorders
- Monoclonal and Polyclonal Antibodies Research
- T-cell and B-cell Immunology
- T-cell and B-cell Immunology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ